Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Nucl Med Biol. 2020 May 12;92:171–183. doi: 10.1016/j.nucmedbio.2020.05.002

Figure 2.

Figure 2.

Quality control data for MEGMIB-5FGGC and [131I]MEGMIB-5F7GGC: A) Size-exclusion HPLC of non-reduced 5F7GGC containing both monomer and dimer (black), reduced 5F7GGC (blue) and MEGMIB 5F7GGC conjugate reaction (red) containing MEGMIB-5F7GGC product and 5F7GGC dimer. B) SDS-PAGE/Phosphor Imaging of [131I]MEGMIB-5F7GGC (right lane) and molecular weight markers (left lane). C) Double reciprocal plot of data from the immunoreactivity assay. D) Data from the saturation binding affinity assay performed with SKOV-3 cells.